Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, December 24, 2022

Effects of cannabinoids on resting state functional brain connectivity: a systematic review

Ask your doctor if cannabinoids post stroke would help brain connectivity and stroke recovery. If your doctor doesn't know the answer, get a new one, you don't have a functioning stroke doctor.

Effects of cannabinoids on resting state functional brain connectivity: a systematic review


https://doi.org/10.1016/j.neubiorev.2022.105014Get rights and content
Under a Creative Commons license
Open access

Highlights

Cannabis and cannabinoids alter rsFC as a function of the cannabinoid examined

In THC intoxication vs placebo reduced connectivity with the NAcc was reported

Limited evidence shows that such effects are offset by co-administration of CBD

Abstract

Cannabis products are widely used for medical and non-medical reasons worldwide and vary in content of cannabinoids such as delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Resting state functional connectivity offers a powerful tool to investigate the effects of cannabinoids on the human brain. We systematically reviewed functional neuroimaging evidence of connectivity during acute cannabinoid administration. A pre-registered (PROSPERO ID: CRD42020184264) systematic review of 13 studies comprising 318 participants (mean age of 25 years) was conducted and reported using the PRISMA checklist. During THC and THCv exposure vs placebo reduced connectivity with the NAcc was widely reported. Limited evidence shows that such effects are offset by co-administration of CBD. NAcc-frontal region connectivity was associated with intoxication levels. Cannabis intoxication vs placebo was associated with lower striatal-ACC connectivity. CBD and CBDv vs placebo were associated with both higher and lower connectivity between striatal-prefrontal/other regions. Overall, cannabis and cannabinoids change functional connectivity in the human brain during resting state as a function of the type of cannabinoid examined.

Keywords

Cannabis
cannabinoids
tetrahydrocannabinol (THC)
cannabidiol (CBD)
functional magnetic resonance imaging (fMRI)
resting state functional connectivity

1. Introduction

Cannabinoid-based products are widely used globally and are becoming increasingly accessible, potent and diversified due to global trends towards the decriminalization of their use and sale (Scheim et al., 2020). Over the past decade, the concentration of cannabis’ main psychoactive compound ∆9-tetrahydrocannabinol (THC) in cannabis products has doubled (Chandra et al., 2019, Freeman et al., 2019b). Meanwhile, the concentration of cannabidiol (CBD), a non-intoxicating cannabinoid with putative therapeutic properties (Bergamaschi et al., 2011) remain stable over time (Freeman et al., 2021). These trends are concerning: THC has addictive (Volkow et al., 2016), intoxicating (Curran et al., 2016), anxiogenic (Crippa et al., 2009) and psychotogenic properties (Hindley et al., 2020). In contrast, CBD putatively mitigates such adverse effects of THC (Englund et al., 2013, Freeman et al., 2019a). Consequently, the burden of the adverse psychosocial outcomes associated with the recent increases of THC likely represent an increasing public health, social and economic problem in the forthcoming years (Hall et al., 2019).

The effects of cannabinoid intoxication have been attributed to the influence of cannabinoids on the brain. Indeed, when cannabis is consumed, THC binds to brain cannabinoid receptors that are densely innervated in selected cortical regions (e.g., prefrontal cortex, hippocampus, cerebellum; Glass et al., 1997; Hashimotodani et al., 2007; Mackie, 2008). These brain pathways are implicated in cognitive processes that are altered with cannabinoid intoxication (e.g., disinhibition, reward processing, motor coordination; Broyd et al., 2016; Dellazizzo et al., 2022; Kroon et al., 2021; Ramaekers et al., 2021); as well as mental health symptoms which transiently increase with cannabis intoxication (e.g., anxiety and psychotic symptoms; Barrett et al., 2018; Colizzi et al., 2016). From a neurobiological perspective, we are yet to uncover in detail the brain pathways underlying cannabinoid intoxication. Notably, the development of functional Magnetic Resonance Imaging (MRI) tools that map brain function in-vivo has generated increasingly sophisticated efforts to identify the neurobiology of cannabinoid intoxication.

Several systematic reviews have integrated findings from experimental fMRI studies in humans during THC and/or CBD intoxication, showing changes in prefrontal, striatal and other regions (Bloomfield et al., 2019, Freeman et al., 2019a, Gunasekera et al., 2020). However, findings have varied significantly across studies, with inconsistent direction and location of the findings (Bloomfield et al., 2019, Freeman et al., 2019a, Gunasekera et al., 2020). The inconsistent results might be (partly) explained by methodological issues. Specifically, several reviews have summarised findings from task-based fMRI while participants perform a variety of cognitive tasks, which may have introduced confounding due to the cognitive demands associated with the task (e.g. cognitive domain examined, task performance, strategy and effort) from that of cannabinoid intoxication (Fox and Greicius, 2010).

Other reviews have synthesised evidence that used heterogeneous neuroimaging techniques (e.g. fMRI, positron emission tomography, single photon emission computed tomography, arterial spin labelling). Thus, they cannot readily disentangle the impact of cannabinoids from that of distinct measures of brain functional integrity (Bloomfield et al., 2019, Freeman et al., 2019a, Gunasekera et al., 2020). In addition, the most up to date search in previous reviews include publications up to July 2019 (Gunasekera et al., 2020) and several new studies have been published since then (Mason et al., 2021, Pretzsch et al., 2019, Wall et al., 2022, Zaytseva et al., 2019).

We conducted the first systematic review of studies that investigated the brain functional changes that occur during acute cannabinoid intoxication by using resting state functional connectivity fMRI – which measures how strongly the function of different brain areas regions is correlated over time without cognitive confounds (van de Ven et al., 2004) - in contrast to task-based fMRI or other functional neuroimaging techniques. Indeed, resting-state fMRI measures spontaneous fluctuations of brain function while people do not overtly perform any cognitively demanding tasks, while they are at rest but awake in the scanner (van de Ven et al., 2004). This technique has been used to identify large-scale neural networks in normative samples and core alterations underlying disease (Fox and Greicius, 2010, Philippi et al., 2020). Resting state fMRI thus holds promise to unpack fundamental functional brain changes that occur with cannabinoid intoxication.

We selected the studies which have been published thus far, that investigated subjects of any age who are psychiatrically, neurologically healthy, and free of regular substance use (other than alcohol and nicotine). We paid specific attention to the influence of cannabinoids and their administration (type, dosage, routes of administration) on the putative resting state functional connectivity phenotype of cannabinoid intoxication (Freeman et al., 2020). We also overviewed the associations between the level of functional connectivity alterations and self-reported intoxication or cognitive performance or both. Finally, we detailed the methodologies used to examine resting state functional connectivity during cannabinoid intoxication to evaluate the standards of research in this area and inform directions for future work.

No comments:

Post a Comment